Open Access

QSAR studies on PIM1 and PIM2 inhibitors using statistical methods: a rustic strategy to screen for 5-(1H-indol-5-yl)-1,3,4-thiadiazol analogues and predict their PIM inhibitory activity

  • Adnane Aouidate1Email author,
  • Adib Ghaleb1,
  • Mounir Ghamali1,
  • Samir Chtita1,
  • M’barek Choukrad1,
  • Abdelouahid Sbai1,
  • Mohammed Bouachrine1 and
  • Tahar Lakhlifi1
Chemistry Central Journal201711:41

https://doi.org/10.1186/s13065-017-0269-1

Received: 2 April 2017

Accepted: 11 May 2017

Published: 19 May 2017

Abstract

Background

Quantitative structure activity relationship was carried out to study a series of PIM1 and PIM2 inhibitors. The present study was performed on twenty-five substituted 5-(1H-indol-5-yl)-1,3,4-thiadiazols as PIM1 and PIM2 inhibitors having pIC50 ranging from 5.55 to 9 µM and from 4.66 to 8.22 µM, respectively, using genetic function algorithm for variable selection and multiple linear regression analysis (MLR) to establish unambiguous and simple QSAR models based on topological molecular descriptors.

Results

Results showed that the MLR predict activity in a satisfactory manner for both activities. Consequently, the aim of the current study is twofold, first, a simple linear QSAR model was developed, which could be easily handled by chemist to screen chemical databases, or design for new potent PIM1 and PIM2 inhibitors. Second, the outcomes extracted from the current study were exploited to predict the PIM inhibitory activity of some studied compound analogues.

Conclusions

The goal of this study is to develop easy and convenient QSAR model could be handled by everyone to screen chemical databases or to design newly PIM1 and PIM2 inhibitors derived from 5-(1H-indol-5-yl)-1,3,4-thiadiazol.

Keywords

PIM1 PIM2 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amines QSAR model

Background

PIM1, PIM2 and PIM3 (proviral integration site for moloney murine leukaemia virus) kinases form a three-member subgroup of serine/threonine kinases family, which share a high level of sequence homology and exhibit some functional redundancy. They attracted recent attention for their potential role in tumorigenesis, tumor cell survival and resistance to antitumor agents, thus, these findings make them an attractive target for cancer therapy [1, 2].

In the literature, several classes of molecules as pyrazines [3], cinnamic acid [4] and pyrrolo carbazole [5] have been designed and synthesized to be able to inhibit the PIM1 and PIM2 as well as to exhibit an anticancer activity, and they have been studied with different approaches so far, but this way is regarded as time consuming and very costly. Hence, in order to reduce time and cost also, to design more potent PIM inhibitors, theoretical research can circumvent these difficulties and allow obtaining precise data while taking advantage of the rapid progress of computing chemical descriptors, which can be obtained easily from publicly available software and servers. Therefore, developing predictive quantitative structure activity relationship (QSAR) models to predict the activity of new synthesized or designed PIM inhibitors is highly desired.

In this context, the QSAR of thiadiazoles still receives considerable attention because these agents represent a large family of multi-biological activity substances and continue to be a source of new drugs as witnessed over recent decades. Thus, it is important to extend these findings with all available data. Recently, a series of some potent PIM1 and PIM2 inhibitors have been designed and reported by Bin Wu and al. [6]. To the best of our knowledge, no QSAR studies have been carried out based on the reported activities of this series. That prompted us to aim an in silico study based on it, as well as to generalize beyond the data to screen and predict inhibitory activity of other analogues molecules.

Quantitative structure–activity relationship (QSAR) has been widely used last years in drug discovery and drug design by medicinal chemists [7, 8] and in various practical applications [9, 10] to provide quantitative analysis of structure and biological activity relationships of compounds. Different QSAR studies were reported to identify important structural features responsible for the biological activity and to develop predictive models for diverse chemicals by different authors [11, 12]. Thus, it becomes necessary to develop a QSAR model for the prediction of activity before synthesis of new PIM1 and PIM2 inhibitors. Because, a successful QSAR model is not only helps to understand relationships between the physicochemical properties and biological activity of any class of molecules, but also provides researchers a deep analysis about the lead molecules to be used in further studies [13].

Therefore, the current research aims to derive highly correlation models, which explain the relationship between the anticancer activity, and the structure of twenty-five compounds based on physicochemical descriptors using several chemometric methods such as genetic function algorithm GFA, multiple linear regression MLR. Consequently, the principal goal of this work is to develop easy and convenient QSAR model could be handled by everyone for screening or designing newly PIM1 and PIM2 inhibitors derived from thiadiazoles.

Methods

PIM1 and PIM2 inhibitory activities of a series of twenty-five of 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amine derivatives were taken from literature [6] each activity was expressed as IC50 (µM) then was converted to pIC50 as pIC50 = −log IC50. Figure 1 and Table 1 show the substituted structures of the studied compounds. For modeling purpose, the data set was split into two sets. Nineteen molecules were randomly chosen to build the quantitative model (training set), and the remaining molecules were used to test the performance of the established model (test set) for both activities. Additionally leave-one-out protocol and Y-randomization were carried out to study the stability of the chosen training sets.
Fig. 1

The chemical structure of the studied compounds

Table 1

Chemical structures and anti-cancer activities of substituted 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amine derivatives

a, bAre the test sets for PIM1 and PIM2 inhibitory activities respectively

Molecular descriptors

All modeling studies were performed using the SYBYL-X 2.0 molecular modeling package (Tripos Inc., St. Louis, USA) running on a windows 7, 32 bits workstation. Three-dimensional structures were built using the SKETCH option in SYBYL. All compounds were minimized under the Tripos standard force field [14] with Gasteiger-Hückel atomic partial charges [15] by the Powell method with a convergence criterion of 0.01 kcal/mol Å. To describe the compound structural diversity and in order to obtain validated QSAR models, the optimized structures were saved in sdf format and transferred to PaDEL server [16] to calculate topological descriptors encode the chemical properties of each compound. Among the calculated descriptors only three descriptors have been chosen as relevant to describe each studied inhibitory activity (Table 2).
Table 2

The three relevant molecular descriptors used in each best QSAR model for each activity

Selected descriptors for PIM1 inhibitory activity

Selected descriptors for PIM2 inhibitory activity

AATS0p

Autocorrelation

GATS8v

Geary autocorrelation of lag 8 weighted by van der Waals volume

maxHBint8

Atom type electrotopological state

AATS3i

Autocorrelation

GATS8v

Geary autocorrelation of lag 8 weighted by van der Waals volume

VR1_Dzm

Barysz matrix

Methodology

After the calculation of all descriptors from PaDEL server, a genetic function algorithm (GFA) analysis for variable selection was applied on the molecular descriptors’ set to choose only the appropriate ones to describe each activity [17]. Subsequently, the number was reduced to three, which is reasonable considering the number of molecules used to build the models according to the rule of five [18]. Then, those three chosen descriptors were used as input to perform an MLR study on each activity until a valid model including: the critical probability p value <0.05 for all descriptors and for the complete model, the Fisher criterion, the determination coefficient, the mean squared error, the multi-colinearity test, and the internal, external validations, in addition to the Y-randomization. Later, those descriptors were also exploited to generate the applicability domain to describe the chemical space for each model.

Statistical analysis

In the present study XLSTAT version 2013 [19] was used to perform multiple linear regression (MLR), which is a statistical method aimed to establish a mathematical relationship between a property of a given system and a set of molecular descriptors that encode chemical information. A genetic function algorithm tool was used for variables selection [17], which is a mathematical technique served to reduce the number of variables used in the data set, as well as to select only the pertinent ones, in which mutation probability was 0.5 the smoothing parameter was 1.0, and cross over probability was 1.0. GFA in this study serves to select significant molecular descriptors from vast number of variables.

Validation

The main objective of a QSAR study is to obtain a model with the highest predictive and generalization abilities. Therefore, two principals (internal validation and external validation) were carried out in order to evaluate the predictive power of the developed QSAR models. For the internal validation, the leave-one-out cross-validation process (Q2) was used to evaluate the stability and the internal capability of the proposed models in the present study. A high Q2 value means a high internal predictive power of a QSAR model and a good robustness. Nevertheless, the study of Globarikh [20] indicated that there is no correlation between the value of Q2 for the training set and predictive ability of the test set, revealing that the Q2 is still inadequate for a reliable estimate of model predictive power for all new chemicals. Thus, the external validation regards the only way to determine both the generalizability and the true predictive power of QSAR models for new chemicals. For this reason, the statistical external validation process was applied to the developed models using a test set as described by Globarikh and Tropsha; Roy and Roy [2022].

Y-randomization test

The obtained models were further validated by the Y-Randomization method [23]. In which the dependent vector (pIC50) is randomly shuffled many times and after every iteration, a new QSAR model is developed. The new QSAR models are expected to have lower Q2 and R2 values than those of the original models. This technique is carried out to eliminate the possibility of the chance correlation. If higher values of the Q2 and R2 are obtained, it means that an acceptable QSAR cannot be generated for this data set because of the structural redundancy and chance correlation.

Results and discussion

Data set for analysis

A QSAR study was carried out for the first time on twenty-five of 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amine derivatives, in order to establish quantitative relationships between their structures and their PIM1 and PIM2 inhibitory activities. The three selected descriptors for each model are shown in Table 2.

Multiple linear regressions MLR

Based on the selected molecular descriptors two mathematical linear models were proposed to predict quantitatively the physicochemical effects of substituents on the PIM1 and PIM2 inhibitory activities using linear regression. In total, nineteen molecules were placed in the training set to build the QSAR models, and the six molecules composed the test set,
$$Y = a_{0} + \sum _{i = 1}^{n} a_{i} x_{i} .$$
For the PIM1 inhibitory activity the best linear model contains three molecular descriptors: GATS8v, AATS0p and maxHBint8 and it is represented by the following equation:
$$pIC50 = 6.92 - 5.84 \times \left( {AATS0p} \right) - 0.27 \times \left( {maxHBint8} \right) + 1072 \times (GATS8v)\varvec{ } \varvec{ }$$
(1)
N = 19, R = 0.87, R2 = 0.726, Q2 = 0.60, MSE = 0.221, F = 16.04, P < 0.0001.
For the PIM2 inhibitory activity the best linear model contains three molecular descriptors: GATS8v, AATS3i and VR1_Dzm and it is represented by the following equation:
$$pIC50 = - 32.31 + 12.8 \times (GATS8v) + 0.16 \times (AATS3i)\varvec{ } - 8.48 \times (VR1\_Dzm)\varvec{ } \varvec{ }$$
(2)
N = 19, R = 0.91, R2 = 0.825, Q2 = 0.73, MSE = 0.184, F = 23.85, P < 0.0001.

R2 is the coefficient of determination, F is the Fisher statistic and MSE is the mean squared error. Higher coefficient of determination and lower mean squared error indicate that the model is more reliable. A P smaller than 0.05 means that the obtained equation is statistically significant at the 95% level. The obtained model were cross-validated by their applicable Q2 values (Q2 = 0.60 and 0.73) respectively, using the leave-one-out (LOO) method. A value of Q2 greater than 0.5 is the basic criteria to qualify a model as valid [20].

The multi-collinearity between the above three descriptors for each model was detected by calculating their variation inflation factors VIF as shown in Table 3. Accordingly, it has been found that the descriptors used in the proposed models have very low-inter-correlation. The VIF [24] was defined as 1/(1−R2), where R is the coefficient of correlation between one descriptor and all the other descriptors in the proposed model. A VIF value greater than 5.0 indicates that the model is unstable; a value between 1.0 and 4.0 indicates that the model is acceptable.
Table 3

Multi-colinearity test

Variables

PIM1 inhibitory activity

PIM2 inhibitory activity

AATS0p

maxHBint8

GATS8v

GATS8v

AATS3i

VR1_Dzm

VIF

2.376

2.343

2.081

1.810

1.960

1.168

The correlations of the predicted and observed activities are illustrated in Fig. 2. The descriptors proposed in Eqs. (1) and (2) by MLR are then used as the input parameters to generate the applicability domains (AD) for both models.
Fig. 2

Correlations of observed and predicted activities (training set in black and test set in red) values calculated using MLR models

Applicability domain

The utility of a QSAR model is its accurate prediction ability for new chemical compounds. So, once the QSAR model is built, its domain of applicability (AD) must be defined. A model is regarded valid only within its training domain and only the prediction for new compounds falling within its applicability domain can be considered reliable and not model extrapolations. The most common method to define the AD, it is based on the determination of the leverage value of each compound [22]. The Williams plot [the plot of standardized residuals versus leverage values (h)] is used in the present study to visualize the AD of the QSAR model.
$$h_{i} = x_{i}^{T} (X^{T} X)^{ - 1} x_{i}$$
where the xi is the descriptor vector of the considered compound, X is the descriptor matrix derived from the training set descriptor values, the threshold is defined as:
$$h^{*} = \frac{3(k + 1)}{n}$$
where n is the number of compound in the training set, k is the number of the descriptors in the proposed model, a leverage (h) greater than the threshold (h *) indicates that the predicted response is an extrapolation of the model and, consequently, it can be unreliable.
The Williams plots of the presented MLR models are shown in Figs. 3 and 4, the applicability domains are established inside a squared area within ±2 standard deviation and a leverage threshold h * of 0.63 for both models.
Fig. 3

Williams plot for the training set and external validation for the PIM1 inhibitory activity of compounds, listed in Table 1 (h * = 0.63 and residual limits ±2)

Fig. 4

Williams plot for the training set and external validation for the PIM2 inhibitory activity of compounds, listed in Table 1 (h* = 0.63 and residual limits ±2)

As shown in the developed Williams plot on the selected descriptors for predicting the PIM1 inhibitory activity the majority of compounds from the data set are in this area, except one (compound 4) from training set exceeds the threshold and it is considered as an outlier compound. This erroneous prediction could probably be attributed to the presence of sulfur on the R1 substituent whereas; the majority of compounds have an NH at this position.

While for the developed Williams plot on the selected descriptors for predicting the PIM2 inhibitory activity the majority of compounds from the data set are fallen within the AD, except two molecules: (compound 2) in training set exceeds the threshold, so, it is considered as an outlier compound. Here, this erroneous prediction could probably be attributed to the unsubstituted R2 whereas; the majority of compounds are substituted at this position.

Y-randomization

The Y-randomization method was carried out to validate the MLR models. Several random shuffles of the dependent variable (pIC50) were performed then after every shuffle, a QSAR was developed and the obtained results are shown in Table 4. The low Q2 and R2 values obtained after every shuffle indicate that the good result in our original MLR models are not due to a chance correlation of the training set.
Table 4

Q2 and R2 values after several Y-randomization tests

Iteration

MLR (PIM1)

MLR(PIM2)

Q2

R2

Q2

R2

1

−0.12

0.32

−0.48

0.82

2

−0.32

0.09

−0.09

0.03

3

−0.60

0.09

−0.14

0.33

4

−0.27

0.24

0.26

0.24

5

−0.19

0.12

0.31

0.07

6

−0.53

0.21

0.43

0.09

7

−0.34

0.11

0.45

0.19

8

−1.59

0.12

0.48

0.20

9

−0.77

0.09

0.54

0.23

10

−0.19

0.20

0.17

0.29

External validation

To test the prediction ability of the obtained MLR models, it is required the use of a test set for external validation. As long as, the models generated on the training set using 19 of 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amine derivatives were used to predict the PIM1 and PIM2 inhibitory activities of the remaining molecules. The parameters of the performance of the generated models are shown in Table 5. It can be seen clearly that the generated models are stable and predictable statically.
Table 5

The statistical results of MLR models with validation techniques

Method/parameter

R

R2

Q2

R2 test

MSE

MLR(PIM1)

0.87

0.726

0.60

0.84

0.222

MLR(PIM2)

0.91

0.825

0.73

0.74

0.184

Both obtained models for predicting the PIM1 and PIM2 inhibitory activities have high coefficients of determination for training (R2 = 0.726 and 0.825) and testing sets (test R2 = 0.84 and 0.74) respectively. Also high Cross-validation coefficients (Q2 = 0.60 and 0.76). So the proposed QSAR models can be used as primary step for screening and designing newly PIM1 and PIM2 inhibitors derived from 5-(1H-indol-5-yl)-1,3,4-thiadiazol.

Screening of 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amines analogues and prediction of their PIM1 and PIM2 inhibitory activities

Overall, this study can be utilized to screen databases to look for new PIM1 and PIM2 inhibitors as well as to predict their inhibitory activities. Therefore, the built models were used to screen the Pubchem database, by searching compounds had 80% similarity with the most active compound of the studied series (compound 16). Twelve compound were gathered as shown in Table 6 and their predicted values were calculated in addition to their leverages (h) to check if they fall in the AD of the proposed models (Table 6; Figs. 5, 6).
Table 6

Predicted values and calculated h of pIC50 (µM) according to different methods

Compound

Molecular structure

Pubchem CID

Pred (PIC50) for PIM1

h

Pred (PIC50) for PIM2

h

1

68328588

7.782

0.122

7.455

0.213

2

45377352

10.367

0.906

9.497

1.117

3

68328129

7.316

0.352

7.243

0.162

4

68327929

8.332

0.102

7.513

0.330

5

68328158

8.311

0.074

7.072

1.109

6

68328259

8.434

0.113

7.958

0.106

7

68328426

8.347

0.089

8.026

0.151

8

68328539

8.137

0.387

6.699

0.111

9

68328547

8.282

0.1023

7.594

0.0964

10

68328676

8.138

0.0739

7.068

0.7669

11

68328891

8.329

0.0860

8.244

0.2909

12

68356801

8.745

0.2543

8.137

0.9468

Fig. 5

Leverage values of the screened compounds from pubchem database for the PIM1 inhibitory activity, listed in Table 7 (h *  = 0.63)

Fig. 6

Leverage values of the screened compounds from the pubchem database for the PIM2 inhibitory activity, listed in Table 7 (h * = 0.63)

For the proposed model to predict the PIM1 inhibitory activity, almost of the compounds have h < h *, so their predicted values are regarded reliable except for compound 45377352 which has a leverage exceeds the threshold (h = 0.90).

While for the proposed model to predict the PIM2 inhibitory activity, it is found that among the twelve chemicals, only four were found to have h > h *, 45377352, 68328158, 68328676 and 68356801 respectively, so, expect for those molecules, the PIM2 predicted inhibitory activity of the eight remaining 5-(1H-indol-5-yl)-1,3,4-thiadiazol analogues is regarded reliable.

Moreover, the 5-(1H-indol-5-yl)-1,3,4-thiadiazol analogues were analyzed for their various properties, Log P, H-bond acceptor (H–A), H-bond donor (H–D), Polar surface area (P.S) (A2), Rotatable Bonds (R.B) and Molecular weight (MW) (g/mol), results shown that they follow the Lipinski’s rule of five for oral bioavailability [25]. Therefore, there are regarded to be acceptable as lead molecules to inhibit the PIM1 and PIM2 kinases.

Conclusions

To predict the PIM1 and PIM2 inhibitory activities of a series substituted 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amines, linear technique was used to propose useful mathematical models to establish quantitative relationships between them and a set of topological descriptors. Both proposed linear models MLR exhibit high determination coefficients, good stabilities and prediction abilities, using only three descriptors for each model. Such as the accuracy and predictability of the proposed models were checked based on the domain of applicability (AD), the Y-randomization and by comparing key statistical indicators, such as the R or R2 of the obtained models, as shown in Table 7. To validate these results, a test set was used, as shown in Table 5.
Table 7

Observed values and calculated values of pIC50 according to different methods

No

pIC50 (obs)

pIC50 PIM1 (pred)

pIC50 PIM2 (pred)

MLR

MLR

1a

5.567

6.781

6.161

2b

5.996

6.769

5.581

3

5.787

6.744

4.604

4

4.657

5.440

6.154

5a

6.458

6.495

7.250

6b

6.010

6.708

7.455

7

6.983

7.793

6.373

8a

7.229

7.967

7.388

9a, b

7.431

7.791

7.708

10

7.677

7.781

7.446

11b

6.644

7.996

8.308

12

6.717

6.622

7.265

13

7.376

7.870

7.252

14

7.920

8.049

7.379

15

8.000

7.844

7.016

16

8.221

8.398

7.487

17

7.744

8.148

7.039

18

7.657

7.638

7.186

19

8.000

8.000

7.334

20

7.387

7.756

6.475

21

6.943

7.965

7.206

22b

7.552

7.689

8.003

23a, b

7.769

8.524

8.223

24a

7.602

8.408

5.947

25

5.889

7.578

7.268

a, bAre the test sets for PIM1 and PIM2 inhibitory activities respectively

Finally, we concluded that the topological descriptors used are able to encode the structural features of the studied compounds. Obviously, the obtained results from each model on this series of compounds were used as primary step for predicting the PIM1 and PIM2 inhibitory activity of 5-(1H-indol-5-yl)-1,3,4-thiadiazol analogues.

Abbreviations

QSAR: 

quantitative structure activity relationship

PIM: 

proviral integration site for moloney murine leukaemia virus kinases

MLR: 

multiple linear regression

AD: 

applicability domain

GFA: 

genetic function algorithm

Q2

cross-validated determination coefficient

N: 

optimum number of components obtained from cross-validated PLS analysis and same used in final non-cross-validated analysis

R2

non-cross-validated correlation coefficient

MSE: 

standard error of the estimate

F: 

F test value

text R2

external validation determination coefficient

Declarations

Authors’ contributions

AA proposed the work; AA carried out the QSAR studies, arranged the results and drafted the manuscript under the guidance of MC, AS, MB and TL. AA and AG, MG and SC did the manuscript revision and final shape. All authors read and approved the final manuscript.

Acknowledgements

We are grateful to the “Association Marocaine des Chimistes Théoriciens” (AMCT) for its pertinent help concerning the programs.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
MCNSL, School of Sciences, University Moulay Ismail

References

  1. Brault L, Gasser C, Bracher F et al (2010) PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers. Haematologica 95:1004–1015. doi:https://doi.org/10.3324/haematol.2009.017079 View ArticleGoogle Scholar
  2. Nawijn MC, Alendar A, Berns A (2011) For better or for worse: the role of Pim oncogenes in tumorigenesis. Nat Rev Cancer 11:23–34. doi:https://doi.org/10.1038/nrc2986 View ArticleGoogle Scholar
  3. Qian K, Lian W, Cywin CL et al (2009) Hit to lead account of the discovery of a new class of inhibitors of pim kinases and crystallographic studies revealing an unusual kinase binding mode. J Med Chem 52:1814–1827. doi:https://doi.org/10.1021/jm801242y View ArticleGoogle Scholar
  4. Schulz MN, Fanghänel J, Schäfer M et al (2011) A crystallographic fragment screen identifies cinnamic acid derivatives as starting points for potent Pim-1 inhibitors. Acta Crystallogr Sect D Biol Crystallogr 67:156–166. doi:https://doi.org/10.1107/S0907444910054144 View ArticleGoogle Scholar
  5. Gadewal N, Varma A (2012) Targeting Pim-1 kinase for potential drug-development. Int J Comput Biol Drug Des 5:137–151. doi:https://doi.org/10.1504/IJCBDD.2012.048303 View ArticleGoogle Scholar
  6. Wu B, Wang HL, Cee VJ et al (2015) Discovery of 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amines as potent PIM inhibitors. Bioorganic Med Chem Lett 25:775–780. doi:https://doi.org/10.1016/j.bmcl.2014.12.091 View ArticleGoogle Scholar
  7. González-Díaz H (2013) Computational prediction of drug-target interactions in medicinal chemistry. Curr Top Med Chem 13:1619–1621View ArticleGoogle Scholar
  8. González-Díaz H, Arrasate S, Sotomayor N et al (2013) MIANN models in medicinal, physical and organic chemistry. Curr Top Med Chem 13:619–641View ArticleGoogle Scholar
  9. Abeijon P, Garcia-Mera X, Caamano O et al (2017) Multi-target mining of Alzheimer disease proteome with Hansch’s QSBR-perturbation theory and experimental-theoretic study of new thiophene isosters of rasagiline. Curr Drug Targets 18:511–521. doi:https://doi.org/10.2174/1389450116666151102095243 View ArticleGoogle Scholar
  10. Todeschini R, Pazos A, Arrasate S, González-Díaz H (2016) Data analysis in chemistry and bio-medical sciences. Int J Mol Sci 17:2105. doi:https://doi.org/10.3390/ijms17122105 View ArticleGoogle Scholar
  11. González-Díaz H, Herrera-Ibatá DM, Duardo-Sánchez A et al (2014) ANN multiscale model of anti-HIV drugs activity vs AIDS prevalence in the US at county level based on information indices of molecular graphs and social networks. J Chem Inf Model 54:744–755. doi:https://doi.org/10.1021/ci400716y View ArticleGoogle Scholar
  12. Duardo-Sánchez A, Munteanu CR, Riera-Fernández P et al (2014) Modeling complex metabolic reactions, ecological systems, and financial and legal networks with MIANN models based on Markov-Wiener node descriptors. J Chem Inf Model 54:16–29. doi:https://doi.org/10.1021/ci400280n View ArticleGoogle Scholar
  13. Gupta SP, Mathur AN, Nagappa AN et al (2003) A quantitative structure-activity relationship study on a novel class of calcium-entry blockers: 1-[(4-(aminoalkoxy)phenyl)sulphonyl]indolizines. Eur J Med Chem 38:867–873View ArticleGoogle Scholar
  14. Clark M, Cramer RD, Van Opdenbosch N (1989) Validation of the general purpose tripos 5.2 force field. J Comput Chem 10:982–1012. doi:https://doi.org/10.1002/jcc.540100804 View ArticleGoogle Scholar
  15. Purcell WP, Singer JA (1967) A brief review and table of semiempirical parameters used in the Hueckel molecular orbital method. J Chem Eng Data 12:235–246. doi:https://doi.org/10.1021/je60033a020 View ArticleGoogle Scholar
  16. Yap CW (2011) PaDEL-descriptor: an open source software to calculate molecular descriptors and fingerprints. J Comput Chem 32:1466–1474. doi:https://doi.org/10.1002/jcc.21707 View ArticleGoogle Scholar
  17. Waller CL, Bradley MP (1999) Development and validation of a novel variable selection technique with application to multidimensional quantitative structure-activity relationship studies. J Chem Inf Model 39:345–355. doi:https://doi.org/10.1021/ci980405r Google Scholar
  18. Hickey JP, Passino-reader DR (1991) Linear solvation energy relationships : “Rules of Thumb” for estimation of variable values. Environ Sci Technol 25:1753–1760View ArticleGoogle Scholar
  19. XLSTATGoogle Scholar
  20. Golbraikh A, Tropsha A (2002) Beware of q2! J Mol Graph Model 20:269–276. doi:https://doi.org/10.1016/S1093-3263(01)00123-1 View ArticleGoogle Scholar
  21. Roy PP, Roy K (2008) On some aspects of variable selection for partial least squares regression models. QSAR Comb Sci 27:302–313. doi:https://doi.org/10.1002/qsar.200710043 View ArticleGoogle Scholar
  22. Gramatica P (2007) Principles of QSAR models validation: internal and external. QSAR Comb Sci 26:694–701. doi:https://doi.org/10.1002/qsar.200610151 View ArticleGoogle Scholar
  23. Veerasamy R, Rajak H, Jain A et al (2011) Validation of QSAR models—strategies and importance. Int J Drug Des Disocov 2:511–519. doi:https://doi.org/10.1016/j.febslet.2005.06.031 Google Scholar
  24. O’Brien RM (2007) A caution regarding rules of thumb for variance inflation factors. Qual Quant 41:673–690. doi:https://doi.org/10.1007/s11135-006-9018-6 View ArticleGoogle Scholar
  25. Lipinski CA (2004) Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 1:337–341. doi:https://doi.org/10.1016/j.ddtec.2004.11.007 View ArticleGoogle Scholar

Copyright

© The Author(s) 2017